I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial):..:
Larkin J
;
Weber J
;
Del Vecchio M
...
info:eu-repo/semantics/altIdentifier/pmid/35964471. , 2022
Link:
https://hdl.handle.net/11365/1221042
RT Journal T1
Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria
UL https://suche.suub.uni-bremen.de/peid=base-ftunivsiena:oai:usiena-air.unisi.it:11365_1221042&Exemplar=1&LAN=DE A1 Larkin J A1 Weber J A1 Del Vecchio M A1 Gogas H A1 Arance A. M A1 Dalle S A1 Cowey C. L A1 Schenker M A1 Grob J. -J A1 Chiarion-Sileni V A1 Marquez-Rodas I A1 Butler M. O A1 Di Giacomo A. M A1 Middleton M. R A1 De la Cruz-Merino L A1 Arenberger P A1 Atkinson V A1 Hill A A1 Fecher L. A A1 Millward M A1 Khushalani N. I A1 Queirolo P A1 Long G. V A1 Lobo M A1 Askelson M A1 Ascierto P. A A1 Mandala M YR 2022 K1 AJCC-8 criteria K1 Distant metastase K1 Ipilimumab K1 Melanoma adjuvant therapy K1 Nivolumab K1 Recurrence-free survival K1 Stage 3 K1 Adjuvants K1 Immunologic K1 Human K1 Neoplasm Staging K1 Melanoma K1 Skin Neoplasms JF info:eu-repo/semantics/altIdentifier/pmid/35964471 LK http://dx.doi.org/https://hdl.handle.net/11365/1221042 DO https://hdl.handle.net/11365/1221042 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)